Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Atuveciclib S-Enantiomer

😃Good
Catalog No. T10465Cas No. 2250279-81-1
Alias BAY-1143572 S-Enantiomer

Atuveciclib S-Enantiomer (BAY-1143572 S-Enantiomer) is a potent and selective CDK9 inhibitor, inhibiting CDK9/CycT1 with an IC50 of 16 nM.

Atuveciclib S-Enantiomer

Atuveciclib S-Enantiomer

😃Good
Catalog No. T10465Alias BAY-1143572 S-EnantiomerCas No. 2250279-81-1
Atuveciclib S-Enantiomer (BAY-1143572 S-Enantiomer) is a potent and selective CDK9 inhibitor, inhibiting CDK9/CycT1 with an IC50 of 16 nM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$2,2586-8 weeks6-8 weeks
50 mgInquiry6-8 weeks6-8 weeks
100 mgInquiry6-8 weeks6-8 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Atuveciclib S-Enantiomer (BAY-1143572 S-Enantiomer) is a potent and selective CDK9 inhibitor, inhibiting CDK9/CycT1 with an IC50 of 16 nM.
Targets&IC50
CDK9-CyclinT1:16 nM
In vitro
Atuveciclib (BAY-1143572) S-Enantiomer reveals very similar in vitro properties compared with Atuveciclib (BAY-1143572), well within the limits of measurement accuracy. However, with multiple batches of Atuveciclib (BAY-1143572) S-Enantiomer, there is a trend toward a slightly lower activity against CDK9 in the biochemical assay (IC 50 CDK9/CycT1: 16 nM) and antiproliferative activity against HeLa cells (IC 50 : 1100 nM) [1].
In vivo
Atuveciclib (BAY-1143572) S-Enantiomer shows blood/plasma ratios close to 1, indicating similar distribution. It has comparable pharmacokinetic properties to its parent compound in rats, with a clearance rate (CL b) of 1.2 L/kg per hour, a steady-state volume of distribution (V ss) of 1.2 L/kg, a half-life (t 1/2) of 0.6 hours, and a bioavailability (F) of 53% [1].
SynonymsBAY-1143572 S-Enantiomer
Chemical Properties
Molecular Weight387.43
FormulaC18H18FN5O2S
Cas No.2250279-81-1
SmilesO(C)C1=C(C=CC(F)=C1)C=2N=C(NC3=CC(CS(C)(=N)=O)=CC=C3)N=CN2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 113 mg/mL (291.67 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5811 mL12.9056 mL25.8111 mL129.0556 mL
5 mM0.5162 mL2.5811 mL5.1622 mL25.8111 mL
10 mM0.2581 mL1.2906 mL2.5811 mL12.9056 mL
20 mM0.1291 mL0.6453 mL1.2906 mL6.4528 mL
50 mM0.0516 mL0.2581 mL0.5162 mL2.5811 mL
100 mM0.0258 mL0.1291 mL0.2581 mL1.2906 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Atuveciclib S-Enantiomer | purchase Atuveciclib S-Enantiomer | Atuveciclib S-Enantiomer cost | order Atuveciclib S-Enantiomer | Atuveciclib S-Enantiomer chemical structure | Atuveciclib S-Enantiomer in vivo | Atuveciclib S-Enantiomer in vitro | Atuveciclib S-Enantiomer formula | Atuveciclib S-Enantiomer molecular weight